(Q44504397)

3 December 2017

title

Lipid-lowering treatment for homozygous familial hypercholesterolaemia (English)

1 reference

3 December 2017

0 references

1 reference

Raul D Santos

1

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

3 December 2017

1 reference

3 December 2017

volume

381

1 reference

3 December 2017

issue

9873

1 reference

3 December 2017

page(s)

1182

1 reference

Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960797-7

7 January 2021

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960797-7

7 January 2021

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960797-7

7 January 2021

Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960797-7

7 January 2021

Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2960797-7

7 January 2021

10.1016/S0140-6736(13)60797-7

Identifiers

DOI

1 reference

3 December 2017

1 reference